Eisai Innovation
Cambridge, Massachusettseisaiinnovation.com
Overview
Eisai Innovation, Inc. is an investment entity formed to add cutting-edge technologies, drug modalities, and digital healthcare solutions into the Eisai network . Eisai Innovation identifies opportunities for the Eisai Group to invest in venture businesses that align with Eisai's goal of contributing to patients, focusing on cutting-edge drug discovery platforms, and new modalities, as well as leading biotechnology in focus areas of neurology, oncology, and global health .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vivacta Biotechnology (Shanghai) Co., Ltd. | Apr 2026 | Series A | Co-investor |
| Excalipoint Therapeutics | Mar 2026 | Seed | Co-investor |
| Tacit Therapeutics | Mar 2026 | Series A | Co-investor |
| Sift Biosciences | Feb 2026 | Pre Seed | Co-investor |
| Sift Biosciences | Feb 2026 | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
